|
Volumn 19, Issue 4, 2007, Pages 225-230
|
Review article optimizing the use of her-2/neu targeting agents in breast cancer : a developing nation perspective.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
LAPATINIB;
MONOCLONAL ANTIBODY;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
TRASTUZUMAB;
BREAST TUMOR;
FEMALE;
HUMAN;
METABOLISM;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
RECEPTOR, ERBB-2;
|
EID: 70349349043
PISSN: 11100362
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (30)
|